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I N T R O D U C T I O N  
While folate is normally transported from cell to cell as CH3-H4PteGIuI*, a 
monoglutamate derivative of tetrahydrofolate, once CH3-H4PteGIu~ enters 
the cell it is rapidly converted to other folate derivatives (e.g. tetrahydrofolate) 
and additional glutamyl residues are added by the enzyme folylpolyglutamate 
synthase (EC 6.3.2.17). In mammalian cells the concentrations of mono- 
glutamate folate derivatives are very low and most folate derivatives bear 
multiple glutamyl residues (1-3), with the predominant forms being penta- 
and hexaglutamates. 
Studies in many laboratories have established that folylpolyglutamates are 
substrates for folate-dependent enzymes and in many cases they have lower 
Km values than the corresponding monoglutamate substrates. Both folyl- and 
antifolylpolyglutamates have also been shown to be potent inhibitors of 
folate-dependent enzymes. Methotrexate, an effective antineoplastic agent, is 
considered to produce its cytotoxic effects by inhibition of dihydrofolate 
reductase (EC 1.5.1.3). Methotrexate is a substrate for folylpolyglutamate 
synthetase and polyglutamylation results in enhanced efficacy and toxicity of 
this agent (4-7). Due to its direct effect on dihydrofolate reductase, 
administration of methotrexate results in profound shifts in cellular folate 
pools (8). Most importantly, cellular levels of dihydrofolate polyglutamates 
rise in response to methotrexate administration, e.g. from less than 1% to 
*The abbreviations used are: AICAR, aminoimidazolecarboxamide ribonucleotide; dUMP, 
2'-deoxyuridine 5'-monophosphate; CH3-H~PteGIun, methyltetrahydropteroylpolyglutamate 
with n glutamyl residues; CH2-H4PteGIun, 5,10-methylenetetrahydropteroylpolyglutamate with 
n glutamyl residues; H2PteGlun, dihydropteroylglutamate with n glutamyl residues; CHO- 
H4PteGlun; formyltetrahydropteroylpolyglutamate with n glutamyl residues; PteGlun, pteroyl- 
polyglutamate with n glutamyl residues; H4PteGlun, tetrahydropteroyi polyglntamate with n 
glutamyl residues; H2folate, dihydrofolate; H4folate, tetrahydrofolate; CH2-H4folate, 5,10- 
methylenetetrahydrofolate; MTX, methotrexate (4-amino-10-methylpteroylglutamate); MTX- 
Glun, methotrexate with a total ofn glutamyl residues; CH3-H4folate, 5-methyitetrahydrofolate; 
HCy, homocysteine; Met, methionine; FAD, flavin adenine dinucleotide; CH=H4folate, 
5,10-raethenyltetrahydrofolate. 
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greater than 30% of the total folate pool of human MCF-7 breast cancer cells 
(8). In vitro studies suggest that a number of folate-dependent enzymes will be 
inhibited by elevated concentrations of either methotrexate or dihydrofolate 
polyglutamates. These enzymes include thymidylate synthase (EC 2.1.1.45) 
(9-11), AICAR transformylase (EC 2.1.2.3) (12) and methylenetetrahydro- 
folate reductase (EC 1.5.1.20) (13). 
Our ability to predict the effects of antifolate drugs and to manipulate them 
for maximal clinical efficacy depends on a detailed understanding of the 
specificity of folate-dependent enzymes for folylpolyglutamate substrates and 
inhibitors, both those enzymes which are targets for chemotherapy such as 
dihydrofolate reductase, thymidylate synthase, AICAR transformylase, and 
GAR transformylase (EC2.1.2.2), and those which are not, but whose 
inhibition might result in toxicity due to interference with cellular processes in 
non-dividing cells. 
MATERIALS AND METHODS 
Isolation and assay of thymidylate synthase from Lactobacillus casei. 
Thymidylate synthase was purified from amethopterin-resistant L. casei by 
the method of Lyon et aL (14). Enzyme was stored prior to use at -70°C in 
50 mM Tris chloride buffer, pH 7.3/20% glycerol in aliquots sufficient for one 
day's use. Under these conditions enzyme activity was stable for several 
months. For kinetic studies spectrophotometric assays were performed at 
25°C and the absorbance changes associated with the conversion of CH2-H4- 
folate to H2folate were measured at 340 nm. The CHz-H4folate was 
generated in the cuvet by condensation of (6-R,S)H4folate and formaldehyde. 
The assay mixture (1 ml) contained 100 mM potassium phosphate buffer, pH 
6.8, 100/~M dUMP, 50mM 2-mercaptoethanol, 6mM formaldehyde and 
PteGlu, and H4folate as indicated. Prior to addition of H4folate, the assay 
solution was equilibrated with nitrogen for 3 min. After addition of H4folate, 
incubation was continued for another 5 min under nitrogen to ensure 
complete formation of CHx-H4folate. The cuvet was sealed with parafilm and 
the assay was initiated by addition of 10/~1 of enzyme. 
Preparation of  folylpolyglutamate substrates and inhibitors. For studies with 
monoglutamate substrate (6-R,S)H4folate was prepared by catalytic hydro- 
genation of PteGlul and purified as described by Ross et aL (15). For 
studies with polyglutamate substrates (6-S)H4PteGlu~ and (6-S)CH3- 
H4PteGlu6 were prepared by enzymatic reduction of PteGlul as described by 
Matthews et al. (16). 
Preparation and assay of  methionine synthase from pig liver. Crude extracts 
of methionine synthase from pig liver were prepared by homogenization in a 
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Waring blendor in 50 mM potassium phosphate buffer, pH 7.2. The enzyme 
was absorbed onto DEAE cellulose equilibrated with the same buffer and the 
DEAE cellulose was collected using filtration through a Buchner funnel. The 
DEAE cellulose was rinsed with 100 mM phosphate buffer and the enzyme 
was batch-eluted with 400 mM phosphate buffer. After dialysis against 50 mM 
phosphate buffer, the enzyme was subjected to ammonium sulfate 
fractionation, and the fraction precipitating between 25 and 45% saturation 
was collected and dialyzed against 50 mM phosphate buffer. The enzyme was 
then applied to a column of DEAE-52, rinsed with 100 mM phosphate buffer 
containing 2/.tM adenosylmethionine, and eluted with a linear gradient of 
100-500 mM phosphate buffer containing 2 #M adenosylmethionine. Fractions 
containing methionine synthase activity were pooled, dialyzed against 50 mM 
phosphate buffer containing 2 lttM adenosylmethionine, brought to 10% 
glycerol and stored until use at -70°C in small aliquots. The enzyme used for 
these studies had a specific activity of 0.019/~moles min-lmg -~ and was 
purified 210-fold from the crude extract. 
Methionine synthase was assayed by measuring the conversion of ~4CH3- 
H4PteGlul and homocysteine to H4PteGlu~ and [~4C-methyl]methionine by a 
modification of the procedure used by Taylor and Weissbach (17). Assay 
mixtures (1 ml) contained 100 mM potassium phosphate buffer, pH 7.2, 
500 #M homocysteine, 95 #M adenosylmethionine, 25 mM dithiothreitol, 5/zM 
cyanocobalamin, and methionine synthase. After incubation for 5 min at 
37°C, 125/.tM (6-S)~4CH3-H4PteGIu~, added as a 6-R,S racemic mixture, was 
introduced to initiate the reaction. After incubation for up to 20 rain at 37°C, 
the reaction was terminated by heating for 2 min at 96°C, and the cooled assay 
mixture was passed over a 0.5 × 3 cm column of Bio-Rad AG I-X8 to separate 
labeled CH3-H4PteGlu ~ from labeled methionine. The formation of labeled 
methionine was determined by scintillation counting. Where tritiated (6- 
S)CH3-H4PteGIu6 was used as the substrate, the same general protocol was 
followed, except that lower concentrations of this substrate were employed for 
the assays, as indicated below. 
RESULTS AND DISCUSSION 
Affinity of Folate-Dependent Enzymes for Folylpolyglutamates 
To provide a firm basis for an understanding of the specificity of folate- 
dependent enzymes for folylpolyglutamylated substrates and inhibitors it is 
desirable to compare dissociation constants for folates which differ only in the 
number of glutamyl residues in the polyglutamate chain. We have elected to 
characterize the four enzymes involved in the metabolism of CH2-H4 folate 
(Fig. 1); viz. serine hydroxymethyltransferase (EC 2.1.2.1) (16), methylenetetra- 
hydrofolate reductase (13), thymidylate synthase (18), and methylenetetra- 
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FIG. 1. Major pathways of folate metabolism in mammalian cells. The enzymes indicated are 1, 
serine hydroxymethyltransferase; 2, methylenetetrahydrofolate reductase; 3, methionine 
synthase; 4, adenosylmethionine synthetase; 5, adenosylmethionine-dependent methyl transferases 
(there are many, with different methyl acceptor specificities); 6, adenosylhomocysteine hydrolase; 
7, thymidylate synthase; and 8, methylenetetrahydrofolate dehydrogenase (one activity of a 
trifunctional protein which catalyzes the three steps required for interconversion of CH2-H4- 
folate and H4folate by way of CH=H4folate and CHO-H4folate). 
hydrofolate dehydrogenase (EC 1.5.1.5) (15). In each case we have used the 
enzyme purified from pig liver, a readily available mammalian tissue, so that 
species variation in folylpolyglutamate specificity will not complicate the 
comparison. Our approach has been to measure the Ki values for a series of 
inhibitory polyglutamates which are not metabolized by the enzyme in 
question (dead-end inhibitors) and which exhibit competitive inhibition with 
respect to the folate substrate. In general such Ki values can be equated with 
dissociation constants characterizing the equilibria between the competitive 
inhibitors and the enzyme forms to which they bind. Kinetic determination of 
Kd values has the advantage that nonspecific binding of the inhibitor to the 
enzyme is generally undetectable. Results from studies of these four enzymes 
are shown in Figure 2. It is apparent that these folate-dependent enzymes all 
bind folylpolyglutamate inhibitors more tightly than the corresponding 
monoglutamates. However, the chain length which is bound most tightly is 
different for each of these enzymes, and the ratio of enzyme affinity for the 
monoglutamate and for the most tightly bound polyglutamate is highly 
variable. Thus methylenetetrahydrofolate reduetase binds HzPteGlu6 430- 
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FIG. 2. Comparison of the affinities oftbe folylpolyglutamate inhibitors of four folate-dependent 
enzymes from pig liver. Semilogarithmic plots of Ki vs. the number of glutamyl residues on the 
inhibitor are shown for methylenetetrahydrofolate dehydrogenase (e), methylenetetrahydro- 
folate reductase (A), serine hydroxymethyltransferase (×), and thymidylate synthase (I). For 
methylenetetrahydrofolate reductase, Ki values were determined kinetically for inhibition of 
enzyme by H2PteGIua inhibitors in the presence of saturating NADPH and varied CH2- 
H~PteGlu~ (13). For thymidylate synthase, Ki values were determined kinetically for inhibition of 
enzyme by PteGlun inhibitors in the presence of saturating dUMP and varied CH2-H4PteGIu~ 
(18). For serine hydroxymethyltransferase, Ka values for the dissociation of CH3-H4PteGlun 
from E'CH3-H4PteGlun.glycine ternary complexes were determined spectrophotometrically 
(16). For methylenetetrnhydrofolate dehydrogenase, Ki values were determined kinetically for 
inhibition of the enzyme by H2PteGlu n inhibitors in the presence of saturating NADP + and varied 
CH2-H~PteGlul (15). 
fold more tightly than H2PteGlut, while methylenetetrahydrofolate 
dehydrogenase binds H2PteGlu 5 only 7-fold more tightly than H2PteGlut. 
Based on extrapolations from these data, we would expect cellular folate- 
dependent enzymes to differ markedly in their susceptibility to inhibition by 
folyl- or antifolylpolyglutamates. Antifolates which are not substrates or 
which are poor substrates for folylpolyglutamate synthetase may differ in their 
cellular effects from derivatives which are polyglutamylated. Studies from 
several laboratories (19-21) have established that introduction of a methyl 
group of N 5 on H4folate greatly reduces the affinity of folylpolyglutamate 
162 R. G. MAIWHEWS, et al. 
synthetase for this compound and suggests possibilities for alteration of 
structurally analogous antifolates in order to manipulate their degree of 
polyglutamylation. 
Effects of  Substrate Polyglutamylation on Catalysis 
If we assume that the interaction between the polyglutamate chain and an 
enzyme will be the same for substrates and for inhibitory substrate analogues, 
this binding energy may be expressed in a variety of ways. The increased 
affinity of an enzyme for polyglutamate substrates may manifest itself in a 
lower Km for the folate substrate. Tighter binding of both polyglutamate 
substrates and products to an enzyme may be due to decreased rates of 
dissociation of these compounds from the enzyme surface and may result in 
product release becoming rate limiting in catalysis with a concomitant 
decrease in Vm~x. Alternatively, binding of a folate polyglutamate may enforce a 
conformational change of the enzyme which alters the affinity of the binary 
complex for a non-folate substrate. In such case, the Km for the folate 
polyglutamate substrate might be the same as or even higher than the Km for 
the monoglutamate, but the Km for the non-folate substrate would be 
decreased in the presence of a folylpolyglutamate substrate (enhanced ligand 
synergism). A third possibility is that the interaction between the 
polyglutamate chain and the enzyme will not be optimal in the Michaelis 
complexes but only in the transition state of the reaction (22). In such case, the 
increased affinity of the enzyme for polyglutamate substrates will appear as an 
increase in Vmax rather than as a decrease in Km for the folate substrate. 
Finally, polyglutamate substrates may be channeled from one active site to 
another in multifunctional proteins, or in macromolecular complexes of 
enzymes while the more weakly bound monoglutamate substrates dissociate 
and then rebind (23). 
In the case of methylenetetrahydrofolate reductase (13) the enhanced 
affinity of the enzyme for folylpolyglutamate inhibitors is mirrored in lower 
values for the Km of CH2-H+PteGIu, substrates with the lowest Km values 
observed with CH2-H+PteGIu 6. In contrast, while PteGlu4 is bound 175-fold 
more tightly to porcine thymidylate synthase than is PteGlul, the K~ for 
CH2-H4PteGIu4 is only 2.7-fold lower than that for CH2-H+PteGIu~ and 
changes in Vmax and in the Km for dUMP are also very small (18). In this case 
steady-state kinetic studies suggest an ordered sequential mechanism with 
dUMP binding prior to CH2-H4PteGIul (equation 1). With CH2-H+PteGIu+, 
(1) 
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the order of substrate binding and product release is reversed (equation 2). 
CH2I-I4f°latel dUMPI dTMP] Hlfolatc 
(2) 
The alteration in the kinetic mechanism presumably results because the 
off-constants characterizing the dissociation of both substrate and product 
from binary complexes with the enzyme are decreased with polyglutamates as 
compared with the monoglutamate. The Km value for the second substrate in 
an ordered sequential mechanism is a complicated function of rate and 
equilibrium constants, and when the mechanism changes, the resultant 
alterations in the rate constants obscure the contribution of K~ to the observed 
Km values for the folate substrates. 
Such changes in kinetic mechanism on going from monoglutamate to 
polyglutamate substrates may be the rule rather than the exception. When the 
kinetic mechanism changes, such that the form of enzyme which binds 
substrate is different for monoglutamate and polyglutamate substrates, the Ki 
value measured for folylpolyglutamate inhibitors may vary depending on 
which folate substrate is used. Allegra et al. (12) have reported that the Ki 
value for MTX-Glu5 interacting with AICAR transformylase is 57 nM when 
measured in competition with CHO-H4PteGlut, but is only 6/~M when 
measured in competition with CHO-H4PteGIus. We have made similar 
observations when measuring Ki values for PteGlu, inhibitors of thymidylate 
synthase from L. casei that are summarized in Table 1. Our studies of 
thymidylate synthase from L. casei suggest that this enzyme too undergoes a 
change in kinetic mechanism with polyglutamate as compared to mono- 
glutamate substrates. Product inhibition studies with CH2-H4PteGIul a n d  
CH2-H4PteGIu6 substrate are summarized in Tables 2 and 3. The results are 
TABLE 1. INHIBITION OF THYMIDYLATE SYNTHASE BY 
PteGlun* 
Inhibitor Substrate Ki app (gM) Substrate Ki app (/,tM) 
PteGlu~ CH2-H4PteGIul 29 CH2-H4PteGlu, 29 
PteGlu2 CH2-H4PteGlul 6 CH2-H4PteGlu2 13 
PteGlu3 CH2-H4PteGlul 1 CH2-H4PteGlu3 9 
PteGlu, CH2-H4PteGlul 0.8 CHz-H4PteGIu4 22 
PteGlu+ CHz-H4PteGlul 0.07 CH2-H4PteGhi~ 2 
*Thymidylate synthase from L. camel was used for these experiments. Assays 
contained 100 ~M dUMP and varied CH2-H4PteGIun. In all cases the observed 
inhibition was competitive with respect to the folate substrate except where I'teGlut 
was the inhibitor - -  in this latter case a small effect on the intercepts of double 
reciprocal plots was also observed. 
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TABLE 2. PRODUCT AND DEAD END INHIBITION PATTERNS 
WITH CHz-H4PteGlul SUBSTRATE 
Varied Fixed Pattern 
Inhibitor substrate substrate Expected* Observed 
PteGlu6 d U M P  CH2-H+PteGIul uncomp uncomp 
dTMP d U M P  CHz-H,PteGlul comp comp 
dTMP CHz-H+PteGIu~ dUMP (sat.) noncomp noncomp 
H2PteGlu~ CH2-H,PteGIu~ dUMP noncomp noncomp 
H2PteGlui d U M P  CHz-H4PteGlul (sat.) uncomp uncomp 
*Expected patterns are those for a kinetic mechanism in which addition of dUMP 
precedes addition of CH2-H4PteGlul and dissociation of H2PteGlut precedes that of 
dTMP. Thymidylate synthase from L. casei was used for these experiments. 
TABLE 3. PRODUCT AND DEAD END INHIBITION PATTERNS 
WITH CH2-H4PteGIu6 SUBSTRATE 
Varied Fixed Pattern 
Inhibitor substrate substrate Expected* Observed 
PteGlu6 d U M P  CHz-H4PteGIu~ n o n c o m p  noneomp 
dTMP d U M P  CH2-H,PteGlu6  n o n c o m p  comp 
dTMP CH2-H+PteGIu6 dUMP (sat.) uneomp uncomp 
H2PteGlu6 CH2-H+PteGlu6 dUMP comp comp 
H2PteGlu~ d U M P  CHz-H4PteGlu6 (sat.) noneomp noncomp 
*Expected patterns are those for a kinetic mechanism in which addition of CH2- 
H4PteGlu6 precedes addition of dUMP and dissociation of dTMP precedes that of 
HzPteGlu+. Thymidylate synthase from L. casei was used for these experiments. 
fully consistent with those obtained using fetal pig liver, and suggest that 
dUMP is bound prior to CH2-H4PteGlut but after CH2-H4PteGIu6 and 
dTMP is released after HzPteGlu~ but before HzPteGlu 6. Our studies also 
suggest that reversal in the order of substrate addition and product release has 
occurred with CH2-H+PteGlu4 (data not shown). Our studies with di- and 
triglutamate substrates suggest that these substrates utilize a random order 
mechanism, where either dUMP or CHz-H4 folate may bind first and either Hz 
folate or dTMP may be released last, and the product inhibition patterns seen 
are inconsistent with either ordered sequential mechanism. 
Incorporation of  Plasma Folate Derivatives into the Cellular Folate Pool 
The normal circulating folate derivative is CH3-H4PteGIu~. Dietary folates 
are generally degraded to the monoglutamate level by intestinal folylpoly- 
glutamate-~/-hydrolases, and the resulting derivatives converted to CH3- 
H4PteGlu~. It is of interest to ascertain how CH3-H4PteGlu~ is incorporated 
into the cellular folate pool after transport across the cell membrane. CH3- 
H4PteGlut is a poor  substrate for folylpolyglutamate synthase (19-21) and is 
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probably not polyglutamylated under in vivo conditions. Thus the first step 
towards incorporation into the cellular folate pool must be metabolic 
conversion to another folylmonoglutamate derivative. As shown in Scheme I, 
only two enzymes catalyze reactions involving CH3-H4PteGIul in mammalian 
cells, namely methylenetetrahydrofolate reductase and cobalamin-dependent 
methionine synthase (EC 2.1.1.13). Both these enzymes show higher affinity 
for polyglutamate than for monoglutamate substrates (13, 24, and data 
presented below). The metabolism of CH3-H4PteGIu~ can be impaired by 
treatment of animals with N20, which inhibits methionine synthase and leads 
to secondary declines in the cellular levels of methionine and AdoMet. Under 
these conditions an increased percentage of the total folate pool is transiently 
present as CH3-H4PteGlu~ derivatives but the total folate pool is depleted 
(25). This depletion of intracellular folate presumably results because CH3- 
H4PteGlut is neither polyglutamylated nor converted to other folate 
derivatives in N20-treated animals and is not then retained by the cell. 
The reaction catalyzed by methylenetetrahydrofolate reductase is shown in 
equation 3. This reaction is irreversible both in vitro and in vivo (26). 
NADPH + CHz-H4folate -- NADP + + CH3-H4folate (3) 
Oxidation-reduction of the substrates is mediated by the enzyme-bound flavin 
which is alternately reduced by NADPH and reoxidized by CH2-H4folate 
(26, 27). The reduction of the enzyme-bound flavin by NADPH constitutes 
the irreversible segment of the reaction, while there is a freely reversible 
equilibrium between enzyme-bound flavin and CH2-H4folate and CH3-H 4- 
folate. The enzyme catalyzes exchange between ~4CH3-H4folate and CH2-H 4- 
folate according to equations 4 and 5 (27). Thus in principle, an exchange 
E'FAD + 14CH3-H4folate --" E'FADH2 + 14CH2-H4folate (4) 
E'FADH2 + CH2-H4folte --" E'FAD + CH3-H4folate (5) 
reaction catalyzed by methylenetetrahydrofolate reductase could be used to 
convert CH3-H4PteGlul to CHz-H4PteGIu~, with the accompanying 
reduction of CHz-H4PteGlun to CH3-H4PteGIu,. Two factors mediate 
against such an exchange reaction playing an important role in cellular 
incorporation of CH3-H,PteGIul. NADPH, which is present at high levels 
(~200/~M) in the cytoplasm of mammalian cells, should compete favorably 
for the oxidized enzyme with CH2-H4PteGlu~, which is bound with roughly 
the same affinity (27) and which is present in much lower concentration in 
cells. Secondly, the activity of methylenetetrahydrofolate reductase is 
regulated by adenosylmethionine (28) and we have now shown that 
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adenosylmethionine inhibits both the reduction of the enzyme-bound flavin 
by CH3-H4folate and the reoxidation of reduced enzyme by CH2-H4folate 
(Green, Ballou and Matthews, unpublished data). 
Alternatively, cellular incorporation of CH3-H~PteGlu~ may be mediated 
by cobalamin-dependent methionine synthase according to equation 6. 
CH3-H4folate + HCy --- H4folate + Met (6) 
Coward and coworkers (24) report a decrease in Km for the folate substrate of 
only 2.6-fold on going from CH3-H4PteGlul to CH3-H4PteGIu 5 using the 
enzyme from bovine brain. However our observations with the partially 
purified enzyme from pig liver are quite different, as shown in Figures 3 and 4. 
Using a mixture of (6-R,S)I4CH3-H4PteGIu] and unlabeled (6-S)CH3- 
H4PteGlu6, a lag phase in the consumption of CH3-H4PteGIu ~ is seen which is 
proportional to the amount of CH3-H4PteGIu6 added. This suggests that the 
Km for CH3-H4PteGIu6 is much lower than that of CH3-H4PteGlu~, such that 
the unlabeled substrate is almost completely consumed before appreciable 
amounts of CH3-H4PteGlu~ are converted to product. This conclusion has 
been tested using a mixture of tritiated CH3-H4PteGIu6 and 14CH3-H4PteGIuI 
and measuring the 3H/14C ratio of the methionine product as a function of the 
time of reaction. The results of this experiment are shown in Figure 4. Direct 
measurements of the Km values of CH3-H4PteGlu t and CH3-H4PteGIu6 
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FIG. 3. Rate of formation of methionine catalyzed by pig liver methionine synthase from 
14CH3-H,PteGiul in the presence of the indicated amounts of unlabeled CH~-H4PteGIu6 (I). The 
concentration of (6-S)CH2-H4PteGIu, was initially 21 kcM, added as a racemic (6-R,S) mixture. 
The CH~-H~PteGIu6 was prepared enzymatically as the (6-S) diastereomer. 
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FIG. 4. Rate of formation of methionine catalyzed by pig liver methionine synthase from a 
mixture of [3H-methyl]-CH3-H4PteGlu6 (4200 dpm per tool) and t4CH3-H4Pte-Glul (2000 dpm 
per nmol). CH3-H,PteGIu~ was added as a racemic (6-R,S) mixture and the concentration of the 
(6-S) diastereomer was 21 #M. The CH3-H4PteGlu6 was prepared enzymatically as the (6-S) 
diastereomer and was present at a concentration of 4.2 #M. 
experiments are shown in Figure 5. A double-reciprocal plot of v vs. [CH3- 
H4PteGlul] is linear, but a similar plot of v vs. [CH3-H4PteGIu6] is markedly 
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FIG. 5. Determination of Km values for CH3-H4PteGium (*) and CH3-H4PteGlu6 (m) substrates 
using methionine synthase from pig liver. 
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nonlinear and suggests that methionine synthase has two classes of binding 
sites for folylpolyglutamates which differ markedly in their affinity. It is quite 
possible that these apparent differences in affinity may indicate negative 
cooperativity associated with substrate binding. 
These preliminary data suggest that methionine synthase will only use 
CH3-H4PteGlu I as a substrate when the cellular pool of CH3-H4PteGIu, is 
largely depleted. The pool size of CH3-H4PteGlun is primarily regulated by 
methylenetetrahydrofolate reductase activity, which in turn is regulated by 
adenosylmethionine levels. Thus incorporation of CH3-H4PteGlul into the 
cellular folate pool appears to require active methionine synthase and 
adequate cellular levels of adenosylmethionine. Studies of Fujii and 
Huennekens (29) have shown that CH3-H 4 folate pools are greatly expanded 
in cobalamin-depleted L1210 cells, and that these cells are unable to use 
CH3-H4PteGIul as an extracellular source of folate. Methionine administration 
partially restores the deficient cellular folate uptake characteristic of cells of 
animals which are cobalamin-deficient or which have been treated with N20 
(30, 31). 
SUMMARY 
The true intracellular substrates for folate-dependent enzymes are 
folylpolyglutamates. We have used measurements of the Ki values of 
folylpolyglutamate dead end inhibitors to assess the relative affinities of 
folate-dependent enzymes for folate derivatives of different polyglutamate 
chain lengths. Studies of four enzymes from pig liver, methylenetetra- 
hydrofolate reductase, serine hydroxymethyltransferase, methylenetetra- 
hydrofolate dehydrogenase and thymidylate synthase, have indicated that 
folylpolyglutamate inhibitors are bound 3-500 fold more tightly than the 
corresponding monoglutamates. The individual enzymes differ in their 
selectivity for polyglutamate vs. monoglutamate inhibitors, and in the chain 
length associated with the greatest affinity of enzyme for inhibitor. We have 
also examined the effect of polyglutamate chain length on the catalytic 
parameters associated with folate substrates. Two enzymes, methylenetetra- 
hydrofolate reductase and serine hydroxymethyltransferase, show decreases 
in K= values for folypolyglutamate substrates. Methylenetetrahydrofolate 
dehydrogenase shows no detectable differences in the catalytic parameters of 
polyglutamate vs. monoglutamate substrates and no change in the order of 
substrate addition or product release. Thymidylate synthase shows small 
effects of Km and Vmax values, but the order of addition of substrates and of 
release of products is reversed with polyglutamate as compared with 
monoglutamate substrates. Our studies with thymidylate synthase from L. 
c a s e i  have shown that the bacterial enzyme also exhibits a greatly increased 
affinity for polyglutamate vs. monoglutamate derivatives of folic acid, and 
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that  reversal in the order  o f  substrate addi t ion and p roduc t  release also occurs  
with polyglu tamate  as compared  with monog lu tamate  substrates. We have 
also studied the polyglu tamate  specificity o f  methionine synthase, which is 
responsible for  the convers ion o f  CH3-H4PteGIu~ into H4PteGlu~. This 
react ion is required for the incorpora t ion  o f  p lasma folate into the cellular 
folate pool ,  because methyl te t rahydrofola te  is a poor  substrate for  
folylpolyglutamate  synthetase. Our  studies demonst ra te  that  CH:H4PteGlum 
metabol ism is potent ly inhibited in the presence o f  CH3-H4PteGlu6, and 
suggest tha t  incorpora t ion  o f  p lasma CH3-H4PteGIu~ will only occur  when 
methylenete t rahydrofola te  reductase is inhibited by adenosylmethionine and 
cellular pools o f  C H : H 4 P t e G I u  6 are at very low levels. 
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